Efficacy of Silodosin in Expulsive Therapy of Lower Ureteral Stones: A Randomized Controlled trial

Efficacy of silodosin in expulsive therapy of lower ureteral stones

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12611000555954

Enrollment

Registered

2011-06-01

Start date

2010-05-01

Completion date

2011-12-31

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

perform a comparative study to evaluate the clinical role of silodosin in the medical expulsive therapy of symptomatic lower ureteral stones.

Interventions

silodosin (4 mg daily) orally for 2 weeks

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Healthy volunteers

Inclusion criteria

patients with radiopaque lower ureteral stones>5mm

Exclusion criteria

urinary tract infections, high-grade hydronephrosis, diabetes, ulcers, or a history of hypersensitivity toa-1 blocker and pregnant women were excluded. Patients with a history of spontaneous stone expulsion, hypotension, or those found to have systolic blood pressure lower than 110 mmHg

Outcome results